Αποτελέσματα Αναζήτησης
30 Αυγ 2023 · A joint WEHI and Doherty Institute study finds the cancer drug venetoclax -- based on a groundbreaking research discovery at WEHI -- can kill hibernating HIV-infected cells and, crucially,...
26 Ιαν 2022 · In a study published Wednesday in Science Translational Medicine, researchers looked at 32 patients that had both cancer and HIV and found that pembrolizumab, which revives the immune system...
26 Ιαν 2022 · An international research collaboration has found the cancer immunotherapy treatment, pembrolizumab, can reverse HIV latency, the ability for the virus to 'hide' inside cells of people living...
10 Αυγ 2020 · Using the knowledge gained from patients functionally cured of HIV with HSCT, we envision a CAR T-cell product for patients with HIV that is autologously derived, capable of targeting multiple antigens (cancer or viral), and with the ability to be protected from HIV infection via gene editing strategies.
4 Απρ 2022 · A drug widely used in HIV therapy has shown to stop disease progression in 25 percent of patients with fourth-line metastatic colorectal cancer.
The introduction of highly active antiretroviral therapy (ART) has deeply modified the outcome of HIV patients by improving their overall survival and ameliorating their quality of life (QoL).
2 Ιουν 2023 · Agents targeting PD-1 and PD-L1 have US Food and Drug Administration (FDA)–approved indications in many HIV-associated cancers, including Hodgkin lymphoma, cervical cancer, head and neck cancer, hepatocellular carcinoma, and non–small-cell lung cancer; however, PWH were excluded from all clinical trials that led to FDA approval of these agents.
